Royal Bank of Canada’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68K | Sell |
3,523
-5,742
| -62% | -$140K | ﹤0.01% | 5332 |
|
|
2025
Q4 | $248K | Sell |
9,265
-40,406
| -81% | -$1.04M | ﹤0.01% | 4635 |
|
|
2025
Q3 | $1.32M | Sell |
49,671
-269,046
| -84% | -$6.95M | ﹤0.01% | 3750 |
|
|
2025
Q2 | $7.32M | Buy |
318,717
+292,638
| +1,122% | +$7.26M | ﹤0.01% | 2267 |
|
|
2025
Q1 | $756K | Sell |
26,079
-2,553
| -9% | -$81.5K | ﹤0.01% | 3685 |
|
|
2024
Q4 | $1.06M | Buy |
28,632
+2,118
| +8% | +$96.8K | ﹤0.01% | 3495 |
|
|
2024
Q3 | $1.29M | Sell |
26,514
-6,670
| -20% | -$293K | ﹤0.01% | 3327 |
|
|
2024
Q2 | $1.33M | Buy |
33,184
+21,045
| +173% | +$872K | ﹤0.01% | 3227 |
|
|
2024
Q1 | $532K | Sell |
12,139
-44,162
| -78% | -$2.28M | ﹤0.01% | 3930 |
|
|
2023
Q4 | $3.48M | Buy |
56,301
+50,512
| +873% | +$2.65M | ﹤0.01% | 2560 |
|
|
2023
Q3 | $267K | Sell |
5,789
-19,660
| -77% | -$1.07M | ﹤0.01% | 4538 |
|
|
2023
Q2 | $1.46M | Buy |
25,449
+21,460
| +538% | +$951K | ﹤0.01% | 3088 |
|
|
2023
Q1 | $149K | Sell |
3,989
-4,777
| -54% | -$157K | ﹤0.01% | 4858 |
|
|
2022
Q4 | $244K | Buy |
8,766
+4,755
| +119% | +$138K | ﹤0.01% | 4700 |
|
|
2022
Q3 | $112K | Buy |
4,011
+644
| +19% | +$21K | ﹤0.01% | 5225 |
|
|
2022
Q2 | $117K | Sell |
3,367
-23,218
| -87% | -$829K | ﹤0.01% | 5223 |
|
|
2022
Q1 | $954K | Buy |
26,585
+19,142
| +257% | +$543K | ﹤0.01% | 3690 |
|
|
2021
Q4 | $174K | Buy |
7,443
+2,919
| +65% | +$59.7K | ﹤0.01% | 5465 |
|
|
2021
Q3 | $87K | Buy |
4,524
+990
| +28% | +$19.4K | ﹤0.01% | 5806 |
|
|
2021
Q2 | $71K | Buy |
3,534
+2,534
| +253% | +$47.7K | ﹤0.01% | 5801 |
|
|
2021
Q1 | $18K | Sell |
1,000
-14,261
| -93% | -$265K | ﹤0.01% | 6479 |
|
|
2020
Q4 | $307K | Buy |
15,261
+100
| +0.7% | +$1.95K | ﹤0.01% | 4526 |
|
|
2020
Q3 | $284K | Buy |
15,161
+1,582
| +12% | +$31.9K | ﹤0.01% | 4295 |
|
|
2020
Q2 | $305K | Sell |
13,579
-471
| -3% | -$8.63K | ﹤0.01% | 4148 |
|
|
2020
Q1 | $209K | Buy |
14,050
+12,782
| +1,008% | +$222K | ﹤0.01% | 4299 |
|
|
2019
Q4 | $24K | Sell |
1,268
-432
| -25% | -$8.29K | ﹤0.01% | 5776 |
|
|
2019
Q3 | $34K | Sell |
1,700
-35
| -2% | -$729 | ﹤0.01% | 5268 |
|
|
2019
Q2 | $37K | Buy |
1,735
+32
| +2% | +$669 | ﹤0.01% | 5427 |
|
|
2019
Q1 | $35K | Sell |
1,703
-1,997
| -54% | -$44.7K | ﹤0.01% | 5358 |
|
|
2018
Q4 | $74K | Sell |
3,700
-1,305
| -26% | -$25.7K | ﹤0.01% | 4885 |
|
|
2018
Q3 | $96K | Buy |
5,005
+4,105
| +456% | +$73.2K | ﹤0.01% | 4881 |
|
|
2018
Q2 | $14K | Sell |
900
-22
| -2% | -$384 | ﹤0.01% | 5697 |
|
|
2018
Q1 | $17K | Buy |
922
+22
| +2% | +$414 | ﹤0.01% | 5501 |
|
|
2017
Q4 | $17K | Sell |
900
-2,317
| -72% | -$43.3K | ﹤0.01% | 5654 |
|
|
2017
Q3 | $57K | Buy |
3,217
+2,304
| +252% | +$37.9K | ﹤0.01% | 5333 |
|
|
2017
Q2 | $16K | Sell |
913
-93
| -9% | -$1.48K | ﹤0.01% | 5620 |
|
|
2017
Q1 | $15K | Sell |
1,006
-13,468
| -93% | -$212K | ﹤0.01% | 5762 |
|
|
2016
Q4 | $267K | Buy |
14,474
+2,655
| +22% | +$51.7K | ﹤0.01% | 4291 |
|
|
2016
Q3 | $224K | Buy |
11,819
+10,245
| +651% | +$186K | ﹤0.01% | 4357 |
|
|
2016
Q2 | $26K | Buy |
1,574
+974
| +162% | +$13.7K | ﹤0.01% | 5391 |
|
|
2016
Q1 | $7K | Buy |
600
+521
| +659% | +$6.14K | ﹤0.01% | 5828 |
|
|
2015
Q4 | $1K | Sell |
79
-828
| -91% | -$10.9K | ﹤0.01% | 6438 |
|
|
2015
Q3 | $10K | Sell |
907
-675
| -43% | -$10.1K | ﹤0.01% | 5871 |
|
|
2015
Q2 | $28K | Buy |
+1,582
| New | +$24.7K | ﹤0.01% | 5522 |
|
|
2015
Q1 | – | Sell |
-2,516
| Closed | -$29K | – | 6102 |
|
|
2014
Q4 | $29K | Buy |
2,516
+16
| +0.6% | +$174 | ﹤0.01% | 5268 |
|
|
2014
Q3 | $29K | Buy |
+2,500
| New | +$26K | ﹤0.01% | 5164 |
|
Other funds holding AMPH
VCM
BTW
Royal Bank of Canada's AMPH Position: Q1 2026 in Review
Royal Bank of Canada reduced its Amphastar Pharmaceuticals (AMPH) stake by 62% in Q1 2026, selling an estimated $140K and leaving 3,523 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #5332.
Royal Bank of Canada first reported a position in AMPH in Q3 2014 and has held it in 46 quarters since. The position peaked at $7.32M in Q2 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Royal Bank of Canada held 3,523 shares of Amphastar Pharmaceuticals worth $68K as of Q1 2026.
- Royal Bank of Canada sold 5,742 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $140K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5332 holding.
- Royal Bank of Canada first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 46 quarters since.
- Royal Bank of Canada's Amphastar Pharmaceuticals position peaked at $7.32M in Q2 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.